Targeting Angiogenesis for Advanced Hepatocellular Carcinoma

Yuji Eso

doi:10.2169/internalmedicine.5923-20

Targeting Angiogenesis for Advanced Hepatocellular Carcinoma

Intern Med. 2021 Feb 1;60(3):321-322. doi: 10.2169/internalmedicine.5923-20. Epub 2020 Sep 19.

Author

Yuji Eso¹

Affiliation

¹ Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Japan.

No abstract available

Keywords: angiogenesis; hepatocellular carcinoma; immune checkpoint inhibitor; immunotherapy; molecular targeted therapy; vascular endothelial growth factor.

Publication types

Editorial
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Carcinoma, Hepatocellular* / drug therapy
Humans
Liver Neoplasms* / drug therapy
Phenylurea Compounds
Quinolines
Ramucirumab

Substances

Antibodies, Monoclonal, Humanized
Phenylurea Compounds
Quinolines
lenvatinib